Alvotech Starts European Trial For High-Concentration Adalimumab

 
• By Aidan Fry
  
HeadStatue
Alvotech is studying in plaque psoriasis patients its biosimilar of AbbVie's high-concentration version of Humira • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products